Exchange: NASDAQ·Updated 07:44 PM EDT
News
all
press releases
Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates
Pulmonx (LUNG) delivered earnings and revenue surprises of +14.29% and +2.34%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
Pulmonx Corporation (NASDAQ:LUNG) Receives Consensus Recommendation of "Hold" from Analysts
Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) has received an average rating of "Hold" from the eight research firms that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold reco...
MarketBeat
Pulmonx (NASDAQ:LUNG) Downgraded to "Sell" Rating by Wall Street Zen
Wall Street Zen lowered Pulmonx from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat
Pulmonx's (LUNG) Buy Rating Reiterated at D. Boral Capital
D. Boral Capital reiterated a "buy" rating and issued a $14.00 price target on shares of Pulmonx in a report on Thursday...
MarketBeat
Pulmonx Q1 Earnings Call Highlights
Pulmonx (NASDAQ:LUNG) reported first-quarter 2026 worldwide revenue of $20.6 million, as management emphasized early progress on commercial execution, continued advancement of its AeriSeal clinical program, and actions to reduce spending and extend its cash runway. Executives reiterated full-year 20...
MarketBeat
Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates
Pulmonx (LUNG) delivered earnings and revenue surprises of 0.00% and +2.52%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Pulmonx (NASDAQ:LUNG) Releases Quarterly Earnings Results, Meets Expectations
Pulmonx (NASDAQ:LUNG - Get Free Report) released its earnings results on Wednesday. The company reported ($0.33) EPS for the quarter, hitting analysts' consensus estimates of ($0.33). Pulmonx had a...
MarketBeat
Pulmonx (LUNG) Projected to Post Earnings on Wednesday
Pulmonx (NASDAQ:LUNG) will be releasing its Q1 2026 earnings after the market closes on Wednesday, April 29. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-29-pulmonx-co-stock...
MarketBeat
Pulmonx Corporation (NASDAQ:LUNG) Short Interest Update
Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) saw a significant drop in short interest in the month of March. As of March 31st, there was short interest totaling 2,857,097 shares, a drop of...
MarketBeat
Hims & Hers Health (HIMS) Soars 11.1%: Is Further Upside Left in the Stock?
Hims & Hers Health (HIMS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks
<
1
2
>

Advertisement|Remove ads.